{"count": 1, "results": [{"_id": "40570636", "pmid": 40570636, "title": "Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage.", "journal": "Biochem Biophys Res Commun", "authors": ["Yan C", "Ye Y", "Liu N", "Zhang D", "Du W", "Li Y", "Li G", "Li C", "Li J", "Ma S", "Dai Z", "Xiong Z", "Wang Y", "Men C", "Bi R", "Duan Q", "Xu W", "Husilengtu", "Cao Y", "Du J", "Shi C"], "date": "2025-06-24T00:00:00Z", "doi": "10.1016/j.bbrc.2025.152241", "meta_date_publication": "2025 Jun 24", "meta_volume": "777", "meta_issue": "", "meta_pages": "152241", "score": 50265.59, "text_hl": "However, the therapeutic benefits of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the realm of @<m>DISEASE_Hemangioma_Cavernous_Central_Nervous_System</m> @DISEASE_MESH:D020786 @@@CCM@@@ remain unclear. ", "citations": {"NLM": "Yan C, Ye Y, Liu N, Zhang D, Du W, Li Y, Li G, Li C, Li J, Ma S, Dai Z, Xiong Z, Wang Y, Men C, Bi R, Duan Q, Xu W, Husilengtu, Cao Y, Du J, Shi C. Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage. Biochem Biophys Res Commun. 2025 Jun 24;777():152241. PMID: 40570636", "BibTeX": "@article{40570636, title={Metformin limits cerebral cavernous malformation development by targeting KLF4-mediated mitochondrial damage.}, author={Yan C and Ye Y and Liu N and Zhang D and Du W and Li Y and Li G and Li C and Li J and Ma S and Dai Z and Xiong Z and Wang Y and Men C and Bi R and Duan Q and Xu W and Husilengtu and Cao Y and Du J and Shi C}, journal={Biochem Biophys Res Commun}, volume={777}, pages={152241}}"}}]}